Patents Assigned to ASTRID PHARMA CORP
  • Patent number: 12667258
    Abstract: A new generation of precision medicine with interfaces processing the predictive feedback over the course of hyperthermia treatment sessions is provided. Implementation of MR-thermometry measurements and real-time spatial imaging can resolve many of the limiting factors currently associated with hyperthermia treatment. More significantly, implementation of artificial intelligence (machine learning) mediated image analysis and database construction can provide the international community with standards for monitoring, and thermal dose calibration.
    Type: Grant
    Filed: August 15, 2019
    Date of Patent: June 30, 2026
    Assignee: ASTRID PHARMA CORP
    Inventors: R. Holland Cheng, Mohammad A. Baikoghli